Thrivent Financial For Lutherans Regenxbio Inc. Transaction History

Thrivent Financial For Lutherans

$52.6 Billion
Q3 2024

A detailed history of Thrivent Financial For Lutherans transactions in Regenxbio Inc. stock. As of the latest transaction made, Thrivent Financial For Lutherans holds 35,706 shares of RGNX stock, worth $343,848. This represents 0.0% of its overall portfolio holdings.

Number of Shares

35,706

Previous 37,619 5.09%

Holding current value

$343,848

Previous $440,000 14.77%

% of portfolio

0.0%

Previous 0.0%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 07, 2024	SELL	$10.49 - $14.39 $20,067 - $27,528	-1,913 Reduced 5.09%	35,706 $375,000
Q2 2024 Aug 13, 2024	BUY	$11.51 - $21.53 $28,867 - $53,997	2,508 Added 7.14%	37,619 $440,000
Q1 2024 May 14, 2024	SELL	$12.17 - $24.61 $11,598 - $23,453	-953 Reduced 2.64%	35,111 $740,000
Q4 2023 Feb 14, 2024	SELL	$12.89 - $20.82 $12,026 - $19,425	-933 Reduced 2.52%	36,064 $647,000
Q3 2023 Nov 14, 2023	BUY	$16.46 - $19.99 $13,530 - $16,431	822 Added 2.27%	36,997 $609,000
Q2 2023 Aug 14, 2023	SELL	$17.23 - $21.71 $19,848 - $25,009	-1,152 Reduced 3.09%	36,175 $723,000
Q1 2023 May 17, 2023	SELL	$18.08 - $24.55 $23,666 - $32,135	-1,309 Reduced 3.39%	37,327 $706,000
Q4 2022 Feb 08, 2023	SELL	$20.4 - $24.73 $436,723 - $529,419	-21,408 Reduced 35.65%	38,636 $876,000
Q3 2022 Nov 14, 2022	BUY	$22.29 - $35.04 $507,119 - $797,195	22,751 Added 61.01%	60,044 $1.59 Million
Q2 2022 Aug 16, 2022	BUY	$19.35 - $35.04 $128,754 - $233,156	6,654 Added 21.72%	37,293 $921,000
Q1 2022 May 13, 2022	BUY	$24.62 - $34.31 $246 - $343	10 Added 0.03%	30,639 $1.02 Million
Q4 2021 Feb 16, 2022	BUY	$30.19 - $40.28 $9,841 - $13,131	326 Added 1.08%	30,629 $1 Million
Q3 2021 Nov 15, 2021	BUY	$29.09 - $45.68 $52,565 - $82,543	1,807 Added 6.34%	30,303 $1.27 Million
Q2 2021 Aug 19, 2021	SELL	$32.46 - $40.48 $4,252 - $5,302	-131 Reduced 0.46%	28,496 $1.11 Million
Q1 2021 May 17, 2021	BUY	$33.61 - $49.95 $129,801 - $192,906	3,862 Added 15.59%	28,627 $976,000
Q3 2020 Nov 10, 2020	SELL	$27.01 - $40.26 $46,754 - $69,690	-1,731 Reduced 6.53%	24,765 $682,000
Q2 2020 Aug 12, 2020	BUY	$27.75 - $43.44 $6,327 - $9,904	228 Added 0.87%	26,496 $976,000
Q1 2020 May 15, 2020	BUY	$21.5 - $54.2 $28,186 - $71,056	1,311 Added 5.25%	26,268 $851,000
Q4 2019 Feb 13, 2020	BUY	$34.54 - $44.87 $3,419 - $4,442	99 Added 0.4%	24,957 $1.02 Million
Q3 2019 Nov 14, 2019	BUY	$31.84 - $50.88 $27,318 - $43,655	858 Added 3.58%	24,858 $885,000
Q2 2019 Aug 13, 2019	BUY	$42.0 - $59.29 $42,168 - $59,527	1,004 Added 4.37%	24,000 $1.23 Million
Q1 2019 May 14, 2019	BUY	$40.82 - $62.45 $74,129 - $113,409	1,816 Added 8.57%	22,996 $1.32 Million
Q4 2018 Feb 15, 2019	BUY	$39.11 - $75.15 $29,019 - $55,761	742 Added 3.63%	21,180 $888,000
Q3 2018 Nov 15, 2018	BUY	$65.0 - $82.15 $132,275 - $167,175	2,035 Added 11.06%	20,438 $1.54 Million
Q2 2018 Aug 14, 2018	BUY	$27.2 - $74.35 $500,561 - $1.37 Million	18,403 New	18,403 $1.32 Million

Others Institutions Holding RGNX

# of Institutions

197

Shares Held

43.2M

Call Options Held

104K

Put Options Held

478K

View Full List

About REGENXBIO Inc.

Ticker RGNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,230,000
Market Cap $416M
Description
REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapy product candidates to deliver genes to cells to address genetic defects or to enable cells in the body to produce therapeutic proteins or antibodies that are intended to impact disease. Its gene therapy product candidates are based on NAV Technology Platform, a proprie...

More about RGNX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Thrivent Financial For Lutherans, based on Form 13F filings with the SEC.

News

Stay updated on Thrivent Financial For Lutherans with notifications on news.

Account

Thrivent Financial For Lutherans Regenxbio Inc. Transaction History